Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone

Renjie Jin, Julie A. Sterling, James R. Edwards, David Degraff, Changki Lee, Serk In Park, Robert J. Matusik

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Patients with advanced prostate cancer almost invariably develop osseous metastasis. Although many studies indicate that the activation of NF-κB signaling appears to be correlated with advanced cancer and promotes tumor metastasis by influencing tumor cell migration and angiogenesis, the influence of altered NF-κB signaling in prostate cancer cells within boney metastatic lesions is not clearly understood. While C4-2B and PC3 prostate cancer cells grow well in the bone, LNCaP cells are difficult to grow in murine bone following intraskeletal injection. Our studies show that when compared to LNCaP, NF-κB activity is significantly higher in C4-2B and PC3, and that the activation of NF-κB signaling in prostate cancer cells resulted in the increased expression of the osteoclast inducing genes PTHrP and RANKL. Further, conditioned medium derived from NF-κB activated LNCaP cells induce osteoclast differentiation. In addition, inactivation of NF-κB signaling in prostate cancer cells inhibited tumor formation in the bone, both in the osteolytic PC3 and osteoblastic/osteoclastic mixed C4-2B cells; while the activation of NF-κB signaling in LNCaP cells promoted tumor establishment and proliferation in the bone. The activation of NF-κB in LNCaP cells resulted in the formation of an osteoblastic/osteoclastic mixed tumor with increased osteoclasts surrounding the new formed bone, similar to metastases commonly seen in patients with prostate cancer. These results indicate that osteoclastic reaction is required even in the osteoblastic cancer cells and the activation of NF-κB signaling in prostate cancer cells increases osteoclastogenesis by up-regulating osteoclastogenic genes, thereby contributing to bone metastatic formation.

Original languageEnglish (US)
Article numbere60983
JournalPLoS One
Volume8
Issue number4
DOIs
StatePublished - Apr 5 2013

Fingerprint

NF-kappa B
prostatic neoplasms
Prostatic Neoplasms
Bone
Chemical activation
Cells
bones
Bone and Bones
Tumors
osteoclasts
Growth
neoplasms
metastasis
Osteoclasts
bone formation
Neoplasms
Osteogenesis
Genes
cells
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Jin, R., Sterling, J. A., Edwards, J. R., Degraff, D., Lee, C., Park, S. I., & Matusik, R. J. (2013). Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone. PLoS One, 8(4), [e60983]. https://doi.org/10.1371/journal.pone.0060983
Jin, Renjie ; Sterling, Julie A. ; Edwards, James R. ; Degraff, David ; Lee, Changki ; Park, Serk In ; Matusik, Robert J. / Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone. In: PLoS One. 2013 ; Vol. 8, No. 4.
@article{f8cc3292ed304c54893698a911d504d8,
title = "Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone",
abstract = "Patients with advanced prostate cancer almost invariably develop osseous metastasis. Although many studies indicate that the activation of NF-κB signaling appears to be correlated with advanced cancer and promotes tumor metastasis by influencing tumor cell migration and angiogenesis, the influence of altered NF-κB signaling in prostate cancer cells within boney metastatic lesions is not clearly understood. While C4-2B and PC3 prostate cancer cells grow well in the bone, LNCaP cells are difficult to grow in murine bone following intraskeletal injection. Our studies show that when compared to LNCaP, NF-κB activity is significantly higher in C4-2B and PC3, and that the activation of NF-κB signaling in prostate cancer cells resulted in the increased expression of the osteoclast inducing genes PTHrP and RANKL. Further, conditioned medium derived from NF-κB activated LNCaP cells induce osteoclast differentiation. In addition, inactivation of NF-κB signaling in prostate cancer cells inhibited tumor formation in the bone, both in the osteolytic PC3 and osteoblastic/osteoclastic mixed C4-2B cells; while the activation of NF-κB signaling in LNCaP cells promoted tumor establishment and proliferation in the bone. The activation of NF-κB in LNCaP cells resulted in the formation of an osteoblastic/osteoclastic mixed tumor with increased osteoclasts surrounding the new formed bone, similar to metastases commonly seen in patients with prostate cancer. These results indicate that osteoclastic reaction is required even in the osteoblastic cancer cells and the activation of NF-κB signaling in prostate cancer cells increases osteoclastogenesis by up-regulating osteoclastogenic genes, thereby contributing to bone metastatic formation.",
author = "Renjie Jin and Sterling, {Julie A.} and Edwards, {James R.} and David Degraff and Changki Lee and Park, {Serk In} and Matusik, {Robert J.}",
year = "2013",
month = "4",
day = "5",
doi = "10.1371/journal.pone.0060983",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

Jin, R, Sterling, JA, Edwards, JR, Degraff, D, Lee, C, Park, SI & Matusik, RJ 2013, 'Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone', PLoS One, vol. 8, no. 4, e60983. https://doi.org/10.1371/journal.pone.0060983

Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone. / Jin, Renjie; Sterling, Julie A.; Edwards, James R.; Degraff, David; Lee, Changki; Park, Serk In; Matusik, Robert J.

In: PLoS One, Vol. 8, No. 4, e60983, 05.04.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone

AU - Jin, Renjie

AU - Sterling, Julie A.

AU - Edwards, James R.

AU - Degraff, David

AU - Lee, Changki

AU - Park, Serk In

AU - Matusik, Robert J.

PY - 2013/4/5

Y1 - 2013/4/5

N2 - Patients with advanced prostate cancer almost invariably develop osseous metastasis. Although many studies indicate that the activation of NF-κB signaling appears to be correlated with advanced cancer and promotes tumor metastasis by influencing tumor cell migration and angiogenesis, the influence of altered NF-κB signaling in prostate cancer cells within boney metastatic lesions is not clearly understood. While C4-2B and PC3 prostate cancer cells grow well in the bone, LNCaP cells are difficult to grow in murine bone following intraskeletal injection. Our studies show that when compared to LNCaP, NF-κB activity is significantly higher in C4-2B and PC3, and that the activation of NF-κB signaling in prostate cancer cells resulted in the increased expression of the osteoclast inducing genes PTHrP and RANKL. Further, conditioned medium derived from NF-κB activated LNCaP cells induce osteoclast differentiation. In addition, inactivation of NF-κB signaling in prostate cancer cells inhibited tumor formation in the bone, both in the osteolytic PC3 and osteoblastic/osteoclastic mixed C4-2B cells; while the activation of NF-κB signaling in LNCaP cells promoted tumor establishment and proliferation in the bone. The activation of NF-κB in LNCaP cells resulted in the formation of an osteoblastic/osteoclastic mixed tumor with increased osteoclasts surrounding the new formed bone, similar to metastases commonly seen in patients with prostate cancer. These results indicate that osteoclastic reaction is required even in the osteoblastic cancer cells and the activation of NF-κB signaling in prostate cancer cells increases osteoclastogenesis by up-regulating osteoclastogenic genes, thereby contributing to bone metastatic formation.

AB - Patients with advanced prostate cancer almost invariably develop osseous metastasis. Although many studies indicate that the activation of NF-κB signaling appears to be correlated with advanced cancer and promotes tumor metastasis by influencing tumor cell migration and angiogenesis, the influence of altered NF-κB signaling in prostate cancer cells within boney metastatic lesions is not clearly understood. While C4-2B and PC3 prostate cancer cells grow well in the bone, LNCaP cells are difficult to grow in murine bone following intraskeletal injection. Our studies show that when compared to LNCaP, NF-κB activity is significantly higher in C4-2B and PC3, and that the activation of NF-κB signaling in prostate cancer cells resulted in the increased expression of the osteoclast inducing genes PTHrP and RANKL. Further, conditioned medium derived from NF-κB activated LNCaP cells induce osteoclast differentiation. In addition, inactivation of NF-κB signaling in prostate cancer cells inhibited tumor formation in the bone, both in the osteolytic PC3 and osteoblastic/osteoclastic mixed C4-2B cells; while the activation of NF-κB signaling in LNCaP cells promoted tumor establishment and proliferation in the bone. The activation of NF-κB in LNCaP cells resulted in the formation of an osteoblastic/osteoclastic mixed tumor with increased osteoclasts surrounding the new formed bone, similar to metastases commonly seen in patients with prostate cancer. These results indicate that osteoclastic reaction is required even in the osteoblastic cancer cells and the activation of NF-κB signaling in prostate cancer cells increases osteoclastogenesis by up-regulating osteoclastogenic genes, thereby contributing to bone metastatic formation.

UR - http://www.scopus.com/inward/record.url?scp=84875917567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875917567&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0060983

DO - 10.1371/journal.pone.0060983

M3 - Article

C2 - 23577181

AN - SCOPUS:84875917567

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e60983

ER -